Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05790538 · ClinicalTrials.gov registry record
Predicting the Impact of Treatment Toxicities on Health During Cancer ( PATTERN )
A clinical trial, sponsored by OHSU Knight Cancer Institute.
- Completed
- Registry status
- 200
- Enrollment target
NCT05790538: Completed study, sponsored by OHSU Knight Cancer Institute.
NCT05790538 is a clinical trial that has completed, run by OHSU Knight Cancer Institute. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05790538 has completed, sponsored by OHSU Knight Cancer Institute.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
This study investigates the effects of treatment from chemotherapy for cancer on symptoms, function, and falls during treatment and through the recovery phase of cancer care. The goal is to identify simple tests that can help medical providers predict which and when patients show increased risk for falls and functional decline and informing rehabilitation providers about which mobility deficits to target.
Primary Outcome
Measured using the neuropathy subscale of the Functional Assessment of Cancer Therapy - Gynecologic Oncology Group Neurotoxicity (FACT-GOG-NTX-13) questionnaire, which assesses the presence, severity and impact of neuropathy symptoms in patients receiving neurotoxic chemotherapy. The scale ranges from 0-52, with lower scores indicating worse quality of life due to neuropathy.
Interventions
- OTHER Survey Administration
- OTHER Medical Device Usage and Evaluation
- OTHER Electronic Health Record Review
- PROCEDURE Assessment of Therapy Complications
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2020-10-22 |
| Est. Completion | 2025-06-06 |
What the finished NCT05790538 record still lists
NCT05790538 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 4 interventions - of which Survey Administration is the first listed.
NCT05790538 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05790538 about?
NCT05790538 is a clinical study titled "Predicting the Impact of Treatment Toxicities on Health During Cancer ( PATTERN )". This study investigates the effects of treatment from chemotherapy for cancer on symptoms, function, and falls during treatment and through the recovery phase of cancer care. The goal is to identify simple tests that can help medical providers predict which and when patients show increased risk for ...
What is the current status of trial NCT05790538?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2020-10-22. Estimated completion is 2025-06-06.
What interventions are being tested in trial NCT05790538?
The interventions under investigation include: Survey Administration (OTHER), Medical Device Usage and Evaluation (OTHER), Electronic Health Record Review (OTHER), Assessment of Therapy Complications (PROCEDURE).
Who is sponsoring clinical trial NCT05790538?
This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI